NASDAQ:AMLI - Nasdaq - CA0272592092 - Common Stock - Currency: USD
TTM (2024-8-31) | 2024 (2024-2-29) | 2023 (2023-2-28) | 2022 (2022-2-28) | 2021 (2021-2-28) | ||||
---|---|---|---|---|---|---|---|---|
Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
Operating Expenses | 26.88M | 39.82M | 36.07M | 23.37M | 12.69M | |||
Research and Development | 7.80M | 14.40M | 15.60M | 5.51M | 1.44M | |||
Selling, General, and Administrative Expenses | 18.89M | 25.31M | 20.38M | 17.83M | 11.25M | |||
Operating Income | -26.88M | -39.82M | -36.07M | -23.37M | -12.69M | |||
Interest Income/Expense | -4.38M | -80.18K | 403.54K | -177.02K | -17.73K | |||
Non Recurring Items | N/A | N/A | N/A | 0.00 | -251.13K | |||
Income Before Taxes | -31.26M | -39.90M | -35.67M | -23.55M | -12.96M | |||
Net Income | -31.26M | -39.90M | -35.67M | -23.55M | -12.96M | |||
EBITDA | -26.50M | -39.53M | -35.98M | -23.34M | -12.69M | |||
Per Share Data | ||||||||
EPS Diluted Total Ops | -0.14 | -0.19 | -0.17 | -0.13 | -0.12 | |||
Non GAAP EPS | N/A | -0.19 | N/A | N/A | N/A | |||
Statistics |
All data in CAD